MOLDOVAN, Dumitru, Jonathan A. BERNSTEIN, Roman HAKL, Grzegorz POREBSKI, Kimberly POARCH, William R. LUMRY a Anurag RELAN. Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. AMSTERDAM: ELSEVIER, 2019, roč. 7, č. 8, s. 2938-2940. ISSN 2213-2198. Dostupné z: https://dx.doi.org/10.1016/j.jaip.2019.05.042. |
Další formáty:
BibTeX
LaTeX
RIS
@article{1593096, author = {Moldovan, Dumitru and Bernstein, Jonathan A. and Hakl, Roman and Porebski, Grzegorz and Poarch, Kimberly and Lumry, William R. and Relan, Anurag}, article_location = {AMSTERDAM}, article_number = {8}, doi = {http://dx.doi.org/10.1016/j.jaip.2019.05.042}, keywords = {C1-INHIBITOR CONCENTRATE}, language = {eng}, issn = {2213-2198}, journal = {JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE}, title = {Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy}, url = {http://dx.doi.org/10.1016/j.jaip.2019.05.042}, volume = {7}, year = {2019} }
TY - JOUR ID - 1593096 AU - Moldovan, Dumitru - Bernstein, Jonathan A. - Hakl, Roman - Porebski, Grzegorz - Poarch, Kimberly - Lumry, William R. - Relan, Anurag PY - 2019 TI - Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy JF - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE VL - 7 IS - 8 SP - 2938-2940 EP - 2938-2940 PB - ELSEVIER SN - 22132198 KW - C1-INHIBITOR CONCENTRATE UR - http://dx.doi.org/10.1016/j.jaip.2019.05.042 L2 - http://dx.doi.org/10.1016/j.jaip.2019.05.042 N2 - Hereditary angioedema (HAE) is a rare (<1 in 50,000) ge-netic disorder characterized by episodes of cutaneous andmucosal angioedema. HAE is caused by insufficient suppressionof complement and contact-system cascades due to a deficiencyof functional C1 inhibitor (C1-INH). It has been demonstratedthat HAE abdominal attacks are more frequent during preg-nancy, but there is no consensus on which trimester is mostassociated with increased attack rates.Some data suggest thatmore severe attacks and symptoms occur during thefirsttrimester, whereas other data suggest a greater number of attacksin the second and third trimesters. Changes in hormone levelsduring pregnancy may exacerbate HAE attacks, and concernswith administration of certain medications during pregnancy cancomplicate HAE management. ER -
MOLDOVAN, Dumitru, Jonathan A. BERNSTEIN, Roman HAKL, Grzegorz POREBSKI, Kimberly POARCH, William R. LUMRY a Anurag RELAN. Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy. \textit{JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE}. AMSTERDAM: ELSEVIER, 2019, roč.~7, č.~8, s.~2938-2940. ISSN~2213-2198. Dostupné z: https://dx.doi.org/10.1016/j.jaip.2019.05.042.
|